Kairos Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	19	20	-	-	-
Enterprise Value	13	16	-	-	-
Last Close Price	0.89	1.52	-	-	-
PB Ratio	2.42	4.09	-	-	-
P/TBV Ratio	2.45	4.29	-	-	-
Debt / Equity Ratio	-	-	-0.31	-0.50	-0.34
Quick Ratio	13.87	1.28	0.04	0.27	0.04
Current Ratio	16.56	4.20	0.04	0.27	0.04
Return on Equity (ROE)	-92.07%	-192.96%	-	-	-
Return on Assets (ROA)	-53.59%	-43.50%	-107.07%	-39.41%	-
Return on Capital (ROIC)	-62.88%	-87.69%	-	-	-
Return on Capital Employed (ROCE)	-73.10%	-49.10%	119.00%	95.60%	166.50%
Earnings Yield	-27.32%	-13.33%	-	-	-
Buyback Yield / Dilution	-55.64%	-9.38%	-1.42%	-11.86%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q